Trulicity is also approved to reduce the risk of major cardiovascular events, such as heart attack, stroke, or death, in adults with type 2 diabetes with known heart disease or multiple cardiovascular risk factors
This research highlights the role of glucagon-like peptide-1 receptor agonists in reducing inflammation and oxidative stress, thereby contributing to their therapeutic efficacy in metabolic and cardiovascular conditions. 6
They all belong to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1RAs), which mimic a hormone (GLP-1) in the body that helps control insulin and blood glucose levels and promotes feelings of satiety
This suggests that GLP-1 improves glucose tolerance not only by stimulating insulin secretion, but also by enhancing insulin-independent glucose uptake
Dosing varies by drug: Ozempic: Once-weekly injection Wegovy: Once-weekly injection (higher dose for weight loss) Rybelsus: Daily oral tablet Trulicity: Once-weekly injection Always follow your healthcare providers instructions for dosage and frequency
These changes give semaglutide a long half-life of about 160h , and it only needs to be injected once a week for glucose control
